Table 4.
Variables | miR-1-3p (n = 453) | |||
---|---|---|---|---|
No. (%) | Mean ± SD | Median | p-Value | |
Pathology stage | ||||
I | 248 (54.7) | 13.24 ± 18.01 | 8.07 | 0.325 a |
II | 115 (25.4) | 10.18 ± 12.27 | 5.19 | |
III | 73 (16.1) | 10.88 ± 10.13 | 6.49 | |
IV | 17 (3.8) | 12.71 ± 20.41 | 6.13 | |
pT stage | ||||
T1 | 157 (34.7) | 15.18 ± 16.56 e | 10.01 | 0.002 b |
T2 | 238 (52.5) | 10.02 ± 15.63 e | 5.95 | |
T3 | 43 (9.5) | 12.68 ± 13.92 | 6.55 | |
T4 | 15 (3.3) | 10.20 ± 7.87 | 6.61 | |
pN stage | ||||
N0 | 306 (67.5) | 12.53 ± 17.29 | 6.74 | 0.772 a |
N1 | 81 (17.9) | 11.46 ± 13.12 | 7.67 | |
N2 | 65 (14.3) | 10.80 ± 10.48 | 6.49 | |
N3 | 1 (0.3) | 3.03 ± | 3.03 | |
pM stage | ||||
M0 | 436 (96.2) | 12.04 ± 15.58 | 6.74 | 0.863 c |
M1 | 17 (3.8) | 12.71 ± 20.41 | 6.13 |
ap-value were estimated by one-way ANOVA test. bp-values were estimated by Kruskal-Wallis 1-way ANOVA test. cp-value were estimated by Student’s t test, e p < 0.001.